Your browser doesn't support javascript.
loading
Impact of etelcalcetide on fibroblast growth factor-23 and calciprotein particles in patients with secondary hyperparathyroidism undergoing haemodialysis.
Hashimoto, Yusaku; Kato, Sawako; Kuro-O, Makoto; Miura, Yutaka; Itano, Yuya; Ando, Masahiko; Kuwatsuka, Yachiyo; Maruyama, Shoichi.
Affiliation
  • Hashimoto Y; Department of Nephrology, Nagoya University Graduate School of Medicine, Aichi, Japan.
  • Kato S; Department of Nephrology, Nagoya University Graduate School of Medicine, Aichi, Japan.
  • Kuro-O M; Division of Anti-Aging Medicine, Center for Molecular Medicine, Jichi Medical University, Tochigi, Japan.
  • Miura Y; Division of Anti-Aging Medicine, Center for Molecular Medicine, Jichi Medical University, Tochigi, Japan.
  • Itano Y; Department of Nephrology, Nagoya University Graduate School of Medicine, Aichi, Japan.
  • Ando M; Department of Advanced Medicine, Nagoya University Hospital, Aichi, Japan.
  • Kuwatsuka Y; Department of Advanced Medicine, Nagoya University Hospital, Aichi, Japan.
  • Maruyama S; Department of Nephrology, Nagoya University Graduate School of Medicine, Aichi, Japan.
Nephrology (Carlton) ; 27(9): 763-770, 2022 Sep.
Article in En | MEDLINE | ID: mdl-35749253
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Fibroblast Growth Factor-23 / Hyperparathyroidism, Secondary Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies Limits: Humans Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Fibroblast Growth Factor-23 / Hyperparathyroidism, Secondary Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies Limits: Humans Language: En Year: 2022 Type: Article